| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1321222 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SAMD4A mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1321222 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SAMD4A mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1321223 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SAMD4 mRNA | CTD | PMID:21570461 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1321223 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SAMD4 mRNA | CTD | PMID:20188158 |
| aflatoxin B1 | increases expression | ISO | RGD:1321222 | 6480464 | Aflatoxin B1 results in increased expression of SAMD4A mRNA | CTD | PMID:21641981 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1321222 | 6480464 | Benzo(a)pyrene results in decreased expression of SAMD4A mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | increases expression | ISO | RGD:1321222 | 6480464 | Benzo(a)pyrene results in increased expression of SAMD4A mRNA | CTD | PMID:21632981 PMID:21871943 |
| benzo[a]pyrene | increases expression | ISO | RGD:1321222 | 6480464 | Benzo(a)pyrene results in increased expression of SAMD4A mRNA | CTD | PMID:21871943 |
| choline | multiple interactions | ISO | RGD:1321223 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SAMD4 gene | CTD | PMID:20938992 |
| cobalt dichloride | decreases expression | ISO | RGD:1321222 | 6480464 | cobaltous chloride results in decreased expression of SAMD4A mRNA | CTD | PMID:19320972 |
| copper(2+) sulfate | increases expression | ISO | RGD:1321222 | 6480464 | Copper Sulfate results in increased expression of SAMD4A mRNA | CTD | PMID:19549813 |
| coumestrol | decreases expression | ISO | RGD:1321222 | 6480464 | Coumestrol results in decreased expression of SAMD4A mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | ISO | RGD:1321222 | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of SAMD4A mRNA | CTD | PMID:19167446 |
| crocidolite asbestos | increases expression | ISO | RGD:1321222 | 6480464 | Asbestos, Crocidolite results in increased expression of SAMD4A mRNA | CTD | PMID:18687144 |
| cyclosporin A | increases expression | ISO | RGD:1321222 | 6480464 | Cyclosporine results in increased expression of SAMD4A mRNA | CTD | PMID:20106945 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of SAMD4A mRNA | CTD | PMID:21266533 |
| fluoxetine | decreases expression | EXP | | 6480464 | Fluoxetine results in decreased expression of SAMD4A mRNA | CTD | PMID:17033635 |
| folic acid | multiple interactions | ISO | RGD:1321223 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SAMD4 gene | CTD | PMID:20938992 |
| furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of SAMD4A gene | CTD | PMID:22079235 |
| glutathione | increases expression | EXP | | 6480464 | Glutathione deficiency results in increased expression of SAMD4A mRNA | CTD | PMID:20621112 |
| hydralazine | multiple interactions | ISO | RGD:1321222 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SAMD4A mRNA | CTD | PMID:17183730 |
| indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of SAMD4A mRNA | CTD | PMID:21396975 |
| L-methionine | multiple interactions | ISO | RGD:1321223 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SAMD4 gene | CTD | PMID:20938992 |
| nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of SAMD4A mRNA | CTD | PMID:22110744 |
| nickel dichloride | increases expression | ISO | RGD:1321222 | 6480464 | nickel chloride results in increased expression of SAMD4 mRNA | CTD | PMID:17312168 |
| paracetamol | affects expression | ISO | RGD:1321223 | 6480464 | Acetaminophen affects the expression of SAMD4 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1321222 | 6480464 | Acetaminophen results in increased expression of SAMD4A mRNA | CTD | PMID:22230336 |
| quercetin | increases expression | ISO | RGD:1321222 | 6480464 | Quercetin results in increased expression of SAMD4A mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:1321222 | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of SAMD4A mRNA | CTD | PMID:19167446 |
| sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of SAMD4A mRNA | CTD | PMID:22110744 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1321222 | 6480464 | tert-Butylhydroperoxide results in increased expression of SAMD4A mRNA | CTD | PMID:15336504 |
| trans-resveratrol | multiple interactions | ISO | RGD:1321222 | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of SAMD4A mRNA | CTD | PMID:19167446 |
| valproic acid | multiple interactions | ISO | RGD:1321222 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SAMD4A mRNA | CTD | PMID:17183730 |
| zinc atom | multiple interactions | ISO | RGD:1321222 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SAMD4A mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:1321222 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SAMD4A mRNA | CTD | PMID:18593933 |